Gene polymorphism association studies in dialysis: the nutrition-inflammation axis
- PMID: 16076356
- DOI: 10.1111/j.1525-139X.2005.18317.x
Gene polymorphism association studies in dialysis: the nutrition-inflammation axis
Abstract
Although traditional risk factors for cardiovascular disease are common in dialysis patients, they alone cannot explain the unacceptably high prevalence of vascular disease in this patient group. Much recent interest has therefore focused on the role of various nontraditional cardiovascular risk factors, such as inflammation, wasting, obesity, vascular calcification, and oxidative stress. In addition, genetic factors such as single nucleotide polymorphisms (SNPs) may significantly influence the immune response, the levels of inflammatory markers and body composition, as well as the prevalence of vascular calcification in this patient group. While genetic variations in the tumor necrosis factor (TNF)-alpha-308 and interleukin (IL)-10 -1082 SNPs seem to be consistently associated with adverse clinical outcome in end-stage renal disease (ESRD) patients, the results regarding genetic variations in the IL-6 gene have been conflicting. To elucidate the respective role of DNA polymorphisms in the IL-6 and C-reactive protein (CRP) genes, as well as genes that encode vascular calcification inhibitors (such as fetuin-A, matrix Gla protein, and osteoprotegerin), sufficiently powered studies are needed in which both the protein product and the specific phenotype are determined. In addition, polymorphisms in genes related to body composition may be excellent candidates for analysis in the ESRD population, since nutritional parameters are strongly associated with adverse events in these patients. It seems conceivable that in the future, prognostic or predictive multigene DNA assays (which allow a simultaneous and rapid assessment of multiple genetic variants) will provide nephrologists with a more precise approach for the identification of "high-risk" ESRD patients and the development of accurate individualized treatment strategies.
Similar articles
-
End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms.J Intern Med. 2005 Jul;258(1):1-12. doi: 10.1111/j.1365-2796.2005.01516.x. J Intern Med. 2005. PMID: 15953127 Review.
-
Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.Can J Physiol Pharmacol. 2008 Apr;86(4):205-9. doi: 10.1139/Y08-018. Can J Physiol Pharmacol. 2008. PMID: 18418430
-
Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease.Blood Purif. 2005;23(5):384-93. doi: 10.1159/000087196. Epub 2005 Jul 27. Blood Purif. 2005. PMID: 16088107
-
Genetics and reverse epidemiology among patients on chronic hemodialysis.Semin Dial. 2007 Nov-Dec;20(6):570-6. doi: 10.1111/j.1525-139X.2007.00361.x. Semin Dial. 2007. PMID: 17991207 Review.
-
Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.Nephrol Dial Transplant. 2009 Sep;24(9):2847-51. doi: 10.1093/ndt/gfp141. Epub 2009 Apr 6. Nephrol Dial Transplant. 2009. PMID: 19349293
Cited by
-
A meta-analysis on correlation between interleukin-6 -174G/C polymorphism and end-stage renal disease.Ren Fail. 2017 Nov;39(1):350-356. doi: 10.1080/0886022X.2017.1281146. Ren Fail. 2017. PMID: 28164733 Free PMC article.
-
The impact of inflammation on bone mass in children.Pediatr Nephrol. 2011 Nov;26(11):1937-46. doi: 10.1007/s00467-010-1733-5. Epub 2011 Jan 1. Pediatr Nephrol. 2011. PMID: 21197596 Free PMC article. Review.
-
Association of TNF-α -308 G > A and ACE I/D gene polymorphisms in hemodialysis patients with arteriovenous fistula thrombosis.Int Urol Nephrol. 2014 Jul;46(7):1419-25. doi: 10.1007/s11255-013-0580-2. Epub 2013 Oct 15. Int Urol Nephrol. 2014. PMID: 24126814
-
The Impact of Vascular Access Types on Hemodialysis Patient Long-term Survival.Sci Rep. 2019 Jul 24;9(1):10708. doi: 10.1038/s41598-019-47065-z. Sci Rep. 2019. PMID: 31341241 Free PMC article.
-
Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis.Int J Biomed Sci. 2008 Sep;4(3):175-8. Int J Biomed Sci. 2008. PMID: 23675086 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous